Skip to main content

Advertisement

Log in

Metastatic disease from chordoma

  • Case Reports
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Chordomas are tumors with a bad prognosis, because of their location, local aggressiveness and high rate of local relapse. Despite of be benign tumors, they have certain capacity of metastasize and a clinical evolution that results interesting. When we analyzed our series with 35 chordomas studied and treated between 1975 and 2002, we found three patients that experienced a systemic dissemination.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sundaresan N, Boriani S, Rothman A, Holtzman R (2004) Tumors of the osseous spine. J Neurooncology 69:273–290

    Article  Google Scholar 

  2. Markwalder TM, Regula V, Markwalder RV et al (1979) Metastatic chordoma. Surg Neurol 12: 473–478

    PubMed  CAS  Google Scholar 

  3. Soo MY (2001) Chordoma: review of clinicoradiological features and factors affecting survival. Australas Radiol 45:427–434

    Article  PubMed  CAS  Google Scholar 

  4. Chetty RC, Levin VC, Kalan MR (1991) Chordoma: a 20-year clinicopathologic review of the experience at Groote Schuur Hospital, Cape Town. J Surg Oncol 46:261–264

    Article  PubMed  CAS  Google Scholar 

  5. Fourney DR, Gokasian ZL (2003) Current management of sacral chordoma. Neurosurg Focus 15(2):E9

    Article  PubMed  Google Scholar 

  6. McPherson CM, Suki D, McCutcheon IE et al (2006). Metastatic disease from spinal chordoma: a 10-year experience. J Neurosurg Spine 5:277–280

    Article  PubMed  Google Scholar 

  7. McMaster ML, Goldstein AM, Bromley CM et al (2001) Chordoma: incidence and survival patterns in the United States, 1973–1995. Cancer Causes Control 12(1):1–11

    Article  PubMed  CAS  Google Scholar 

  8. Tai PT, Craighead P, Liem SK et al (2000) Management issues in chordoma: a case series. Clin On col (R Coll Radiol) 12(2):80–86

    CAS  Google Scholar 

  9. St. Martin M, Levine SC (2003) Chordomas of the skull base: manifestations and management. Curr Opin Otolaryngol Head Neck Surg 11:324–327

    Article  PubMed  Google Scholar 

  10. Romero J, Cárdenes H, De la Torre A et al (1993) Chordoma: results of radiation therapy in eighteen patients. Radiother Oncol 29:27–32

    Article  PubMed  CAS  Google Scholar 

  11. Catton C, O’sullivan B, Bell R et al (1996) Chordoma: long-term follow-up after radical photon irradiation. Radiother Oncol 41:67–72

    PubMed  CAS  Google Scholar 

  12. Igaki H, Tokuuye K, Okumura T et al (2004) Clinical results of proton beam therapy for skull base chordoma. Int J Radiat Oncol Biol Phys 60(4):1120–1126

    PubMed  Google Scholar 

  13. Mendenhall WM, Mendenhall CM, Lewis SB et al (2005) Skull base chordoma. Head Neck 27(2):159–165

    Article  PubMed  Google Scholar 

  14. Imai R, Kamada T, Tsuji H et al (2004) Carbon ion radiotherapy for unresectable sacral chordoma. Clin Cancer Res 10:5741–5746

    Article  PubMed  CAS  Google Scholar 

  15. Casali PG, Stacchiotti S, Sangalli C et al (2007) Curr Opin Oncol 19:367–370

    Article  PubMed  Google Scholar 

  16. Jacob HE (1994) Chemotherapy for cranial base tumors. J Neurooncol 20:327–335

    Article  PubMed  CAS  Google Scholar 

  17. Schonegger K, Gelpi E, Prayer D et al (2005) Recurrent and metastatic clivus chordoma: systemic palliative therapy retards disease progression. Anticancer Drugs 16(10):1139–1143

    Article  PubMed  Google Scholar 

  18. Fleming GF, Heiman PS, Stephens JK et al (1993) Dedifferentiated chordoma: response to aggressive chemotherapy in two cases. Cancer 72:714–718

    Article  PubMed  CAS  Google Scholar 

  19. Auger M, Raney B, Callender D et al (1994) Metastatic intracranial chordoma in a child with massive pulmonary tumor emboli. Fetal Pediatr Pathol 14:763–770

    Article  CAS  Google Scholar 

  20. Casali PG, Messina A, Stracchiotti S et al (2004) Imatinib mesylate in chordoma. Cancer 101: 2086–2097

    Article  PubMed  CAS  Google Scholar 

  21. Hof H, Welzel T, Debus J (2006) Effectiveness of cetuximab/gefitinib in the therapy of a sacral chordoma. Onkologie 29:572–574

    Article  PubMed  Google Scholar 

  22. Clinical Trial Phase II. Efficacy and Safety of Imatinib in Chordoma, Milano, Italy. Novartis. NCT00150072/CSTI571BIT15

  23. Bergh P, Kindblom LG, Gutenberg B et al (2000) Prognostic factors in chordoma of the sacrum and mobile spine (39 patients). Cancer 88(9):2122–2134

    Article  PubMed  CAS  Google Scholar 

  24. Chambers PW, Schwinn CP (1979) Chordoma. A clinicopathologic study of metastasis. Am J Clin Pa thol 72(5):765–776

    CAS  Google Scholar 

  25. St. Delank KS, Kriegsmann J, Drees PH et al (2002) Metastasising chordoma of the lumbar spine. Eur Spine J 11(2):167–171

    Article  Google Scholar 

  26. Higinbotham NL, Phillips RF, Farr HW, Husyu HO (1967) Chordoma. Thirty-five-year study at Memorial Hospital. Cancer 20:1841–1850

    Article  PubMed  CAS  Google Scholar 

  27. Heffelfinger M J, Dahlin DC, MacCarty CS, Beabout JW (1973) Chordomas and cartilaginous tumors at the skull base. Cancer 32:410–420

    Article  PubMed  CAS  Google Scholar 

  28. Asano S, Kawahara N, Kirino T (2003) Case report. Intradural spinal seeding of a clival chordoma. Acta Neurochir 145:599–603

    Article  CAS  Google Scholar 

  29. Baratti D, Gronchi A, Pennachioli E et al (2003) Chordoma: natural history and results in 28 patients treated at a single institution. Ann Surg Onco 10:291–296

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gloria Vergara.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vergara, G., Belinchón, B., Valcárcel, F. et al. Metastatic disease from chordoma. Clin Transl Oncol 10, 517–521 (2008). https://doi.org/10.1007/s12094-008-0243-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-008-0243-4

Keywords

Navigation